Paul Weiss
1285 Avenue of the Americas
New York, NY 10019-6064
212-373-3532 (direct)
212-492-0532 (direct fax)
212-373-3000 (firm)
212-757-3990 (firm fax)
A partner in the Litigation Department, Catherine Nyarady specializes in patent litigation and is registered to practice in the United States Patent and Trademark Office. She has represented major corporate clients in patent litigations involving a wide range of technologies.
Catherine represented Edwards Lifesciences, the industry leader in artificial heart valves, in multiple litigations and related proceedings, including litigations against Medtronic, Inc. regarding transcatheter heart valves (THV). In 2014, Edwards secured an injunction order against the U.S. launch of Medtronic’s THV products, leading to a settlement in which Medtronic paid to Edwards over $1 billion. This was preceded by two major trial victories: a 2010 jury award of $74 million to Edwards (affirmed on appeal before the U.S. Court of Appeals for the Federal Circuit, certiorari denied) and a 2014 jury award to Edwards of over $393 million.
Catherine is regularly recognized for her work in patent litigation by leading publications such as The Legal 500. In the most recent editions, Catherine has been described by sources as having “the big advantage of being a top class litigator combined with a very extensive scientific understanding” and being "very good with tough issues and witnesses."
Cases illustrating Catherine's patent litigation experience include her representation of:
Catherine has also tried trademark cases. Her trademark experience includes her representation of Time4Media before the U.S. Patent and Trademark Office in the successful defense of trademark opposition proceedings involving the Popular Science mark, Time Warner Entertainment (HBO) in the successful defense in a full jury trial of trademark infringement litigation, and Mermaid Seafoods in the favorable settlement and dismissal of trademark infringement claims against Mermaid Seafoods during a bench trial.
Catherine received her B.S. in Chemical Engineering from the Massachusetts Institute of Technology in 1993 where she was a T.J. Watson Scholar. She received her J.D. in 1996 from Cornell Law School where she was an editor of the Cornell Journal of Law and Public Policy and Chancellor of the Moot Court Board.
Catherine authored a chapter on "Settling Patent Cases" in the leading treatise on the law of settlement agreements and the settlement process, Settlement Agreements in Commercial Disputes: Negotiating, Drafting and Enforcement, published by Wolters Kluwer. Catherine is a member of The American Intellectual Property Law Association and The New York Intellectual Property Law Association.
See Library Tab for articles, publications and presentations by Catherine Nyarady
Apr 20, 2015 | News
Nichia Prevails in Patent Infringement Suit
Mar 25, 2015 | Publications
May 23, 2014 | News
Edwards Lifesciences Settles Heart Valve Patent Wars With Medtronic for Over $1 Billion
Apr 11, 2014 | News
Edwards Lifesciences Attains Another Major Patent Victory Against Medtronic
Jan 23, 2014 | News
Edwards Lifesciences Achieves Another Major Patent Victory Against Medtronic
Jan 16, 2014 | News
Paul, Weiss Wins $393 Million Jury Verdict for Edwards Lifesciences in Patent Litigation
Feb 14, 2013 | News
Ericsson Completes Sale of Patent Portfolio to Unwired Planet
Jan 10, 2013 | News
Ericsson Agrees To Sell Patent Portfolio to Unwired Planet
Dec 17, 2012 | News
Reckitt Benckiser Acquires Schiff Nutrition for $1.4 Billion
Nov 29, 2012 | News
John Nathan and Catherine Nyarady Named AmLaw’s “Litigators of the Week”
Apr 01, 2015
Paul, Weiss Included in The National Law Journal’s Top 100 Verdicts of 2014
Dec 02, 2014
Catherine Nyarady Selected for Law360 Intellectual Property MVP Award
Nov 20, 2014
Four Paul, Weiss Partners Win Law360 MVP Awards
May 06, 2013
The National Law Journal Names Paul, Weiss to its “Intellectual Property Hot List”
Nov 29, 2012
John Nathan and Catherine Nyarady Named AmLaw’s “Litigators of the Week”
Thank you for your interest in Lawdragon.